Clinical trial

Study of Bronchodilation Effects of Cetirizine

NCT01781507

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-06-01

PhasePHASE4

Study timeline

Study start (unknown)2011-06-01Date precision: month

Registry last updated2013-09-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Allergic Rhinitisunresolved

Asthmaunresolved

Interventions

CetirizineDRUG · verified · RxNorm: cetirizine

PlaceboDRUG

Sponsors & collaborators

California Allergy and Asthma Medical Group, Inc.lead sponsor

McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.collaborator

Mapped research locations

Los AngelesCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01781507 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.